Dr. Unger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
792 College Pkwy
Ste 207
Colchester, VT 05446Phone+1 802-655-3400Fax+1 802-655-9170
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1989 - 1992
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1986 - 1989
- Harvard Medical SchoolClass of 1986
Certifications & Licensure
- VT State Medical License 1990 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2012
- Fellow (FACP) American College of Physicians, 2006
Clinical Trials
- Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer Start of enrollment: 2009 Sep 01
- Evaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain Start of enrollment: 2011 May 01
Publications & Presentations
PubMed
- 29 citationsChemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or H...Beverly Moy, R. Bryan Rumble, Steven E. Come, Nancy E. Davidson, Angelo Di Leo
Journal of Clinical Oncology. 2021-07-29
Professional Memberships
- Member
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: